Estrogen in non allergic rhinitis

Phase 3

Recruiting

• Conditions: J30.0; Vasomotor rhinitis.; Vasomotor rhinitis

• Registration Number: IRCT20200926048841N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 25

Inclusion Criteria

Menopausal women 12 months after their last menstrual bleeding
Symptoms of nasal congestion (feeling of fullness in the nose, feeling of discomfort and heaviness in the nose - feeling of reduced airflow in the nose, loss of smell or mouth breathing)

Exclusion Criteria

Use of drugs affecting the nasal airway and nasal mucosa (systemic and local)
Systemic underlying diseases
Previous history of rhinoplasty and sinus surgery
Obstructive symptoms before menopause
Presence of known sinonasal diseases, including pulpitis, chronic sinusitis, sinonasal tumors (both benign and malignant)
Smoking and inhaled drugs
Occupational exposure to chemical stimulants and its history
Patients w?ho did not have the proper cooperation for rhinomanometry, endoscopy and the use of drugs and follow-up
Patients for whom estrogen use is contraindicated

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effect of estrogen on rhinitis. Timepoint: Three months after treatment. Method of measurement: Rhinomanometry.